AI in Healthcare: Former NHC Official Says Technology Can Only Assist, Never Replace, Physicians

Deep News
2 hours ago

In an era where healthcare demands are evolving and populations are aging rapidly, the question of how to balance medical progress with humanistic care has become increasingly urgent. The challenge lies in integrating technological advances while preserving the essential human elements of medicine.

Xiong Xianjun, former Director of the Medical Services Management Department at the National Healthcare Security Administration and teaching professor at Peking Union Medical College, recently shared his insights on the future of medicine in an AI-driven world. He addressed how artificial intelligence might reshape healthcare over the next five to ten years, emphasizing both its potential and its inherent limits.

Where the Future of Medicine Is Heading

Xiong expressed confidence that AI will catalyze major breakthroughs in drug innovation and novel therapeutic approaches over the coming decade. More significantly, he believes foundational research in basic medical theory will see substantial advancement, creating a solid foundation for pharmaceutical and medical innovation. These dual breakthroughs could lead to an abundance of new medications and treatment modalities.

When discussing clinical applications, Xiong acknowledged that AI serves as an excellent supporting tool for physicians, potentially improving diagnostic accuracy. However, he drew a firm distinction: AI cannot replace the practice of medicine itself. Medicine is not purely technical; it encompasses profound humanistic care and compassion that technology simply cannot replicate. As he put it, if medicine were only about technical service, then much more would be replaceable, but the human touch remains irreplaceable.

Concerns About Over-Reliance on AI

Xiong voiced particular concern about younger doctors who may lack extensive clinical experience but might quickly default to AI recommendations. When a physician's own decision-making capacity is lower than that of the AI system, they will inevitably defer to the machine's judgment. Yet AI systems are fallible and can produce errors. His advice is clear: whether young or senior, doctors should treat AI as a valuable assistant but never delegate their own judgment entirely. Even when AI provides an answer, the physician must personally review the patient and examine the scans carefully, albeit perhaps with less strain.

The Impact on Lifespan and Disease

Regarding potential breakthroughs like gene therapy and their effect on human longevity, Xiong remained measured. Having studied medicine himself but not practiced for years, he declined to make specific predictions. He reasoned that AI will likely create new drugs and technologies that improve clinical diagnosis, inevitably extending average life expectancy, though the exact magnitude remains unknown. Whether humanity might someday achieve immortality is, in his view, beyond anyone's capacity to say with certainty.

Challenges for Healthcare Security and Cost

Addressing whether medical insurance systems might face new challenges from AI-driven changes, Xiong acknowledged uncertainty. While AI could potentially reduce certain medical costs, the broader trend shows that technological advancement typically drives overall healthcare spending upward. This increase in total expenditure does not necessarily equate to reduced efficiency; conversely, it might enable smarter spending that purchases more value for the same money.

On the question of whether AI hospitals or AI doctors might emerge, Xiong was definitive: such scenarios are impossible. AI cannot become a physician, cannot replace doctors, and exists only as an assistant to them. From both a scientific and healthcare management perspective, concepts like AI doctors or AI-led hospitals are fundamentally untenable.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10